The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and ...

Vinay Prasad, MD, MPH, a frequent critic of the FDA and COVID-19 lockdowns and vaccination policies, will be the next ...

肿瘤学家Vinay Prasad，一位对COVID-19应对措施持有分歧意见的批评者，将成为美国食品药品监督管理局 (FDA)的新任疫苗监管者。FDA专员Martin Makary周二在社交媒体上宣布了这一消息。Prasad将负责FDA生物制品评估与研究中心 (CBER)，该中心负责批准和监管疫苗及其他生物制品，如基因疗法和血液制品。Makary在社交媒体上表示：“Prasad博士为CBER带来了 ...

The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics ...

The Food and Drug Administration announced Tuesday it has picked a new head of its center charged with vaccine approvals and other biologics products: Dr. Vinay Prasad, a vocal critic of the agency's ...

In his new role with the FDA, Dr. Vinay Prasad will oversee the regulation of costly drugs, including vaccines, gene ...

(Reuters) -The US Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized COVID-19 ...

Not Vinay Prasad. The new top regulator of vaccines and gene therapies at the Food and Drug Administration has never shied ...

The FDA has chosen Dr Vinay Prasad, a professor at UCSF, to lead its Center for Biologics Evaluation and Research.

FDA Commissioner Marty Makary named Vinay Prasad, a hematologist oncologist and critic of the Covid-19 vaccine for children, ...

FDA Commissioner Marty Makary on Tuesday named Indian-origin hematologist oncologist Vinay Prasad as the next director of the ...

Prasad's appointment marks the latest addition of a medical skeptic and critics of COVID-19 policies to federal health leadership.